Patients with glioma experience multidimensional symptoms that reduce their functional status, quality of life, and survival, and these symptoms may be associated with inflammation.
This study applied network analysis to examine and visualize the relationship between multidimensional symptom experiences and inflammatory biomarkers and assess the symptom networks of multidimensional symptom experiences over time in patients with glioma.
